MNDRX Mutual Fund
MNDRX Mutual Fund
MNDRX Mutual Fund
MFS New Discovery Fund Class R2
MNDRX Mutual Fund Overview
MNDRX Mutual Fund (MFS New Discovery Fund Class R2) is managed by MFS Investment Management with $12.2M in net assets. MNDRX expense ratio is 1.46%, holding 121 positions across sectors including Health Care, Information Technology, Industrials. Inception date: 2003-10-31.
MNDRX performance shows a YTD return of 12.05%. The 1-year return is 14.52% and the 5-year return is -0.60%.
MNDRX top holdings include Cash & Cash Equivalents (4.1%), Mfs Institutional Money Market Portfolio (4.0%), Caci International Inc, Class A (2.5%), Ligand Pharmaceuticals Inc (2.3%), Merit Medical Systems Inc (2.1%). Go to all MNDRX holdings, MNDRX sectors, or MNDRX dividends.
MNDRX can be compared against other funds. Use MNDRX overlap to find shared positions, or MNDRX vs another fund for a side-by-side view. MNDRX alternatives are available via the screener, along with tax-loss harvesting opportunities.